KPWS
DNA icon

Kestra Private Wealth Services’s Ginkgo Bioworks DNA Stock Holding History

Kestra Private Wealth Services’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-480
Closed -$6.42K – 1396
2024
Q2 		$6.42K Sell
480
-12
-2% -$358 ﹤0.01% 1347
2024
Q1 		$22.8K Sell
492
-110
-18% -$5.69K ﹤0.01% 1282
2023
Q4 		$40.7K Buy
602
+25
+4% +$1.53K ﹤0.01% 1180
2023
Q3 		$41.7K Buy
577
+27
+5% +$2.16K ﹤0.01% 1131
2023
Q2 		$40.9K Buy
550
+165
+43% +$9.77K ﹤0.01% 1050
2023
Q1 		$20.5K Buy
385
+10
+3% +$634 ﹤0.01% 1039
2022
Q4 		$25.4K Buy
+375
New +$34.5K ﹤0.01% 881

Other funds holding DNA

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACG
Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Kestra Private Wealth Services's DNA Position: Q3 2024 in Review

Kestra Private Wealth Services sold out of Ginkgo Bioworks (DNA) in Q3 2024, closing a stake of 480 shares — an estimated $6.42K sold.

Kestra Private Wealth Services first reported a position in DNA in Q4 2022 and held it in 7 quarters. The position peaked at $41.7K in Q3 2023. 159 funds tracked by Wall St. Rank hold DNA as of Q3 2024.

  • Kestra Private Wealth Services reported no remaining Ginkgo Bioworks position as of Q3 2024 after selling out during the quarter.
  • Kestra Private Wealth Services sold 480 Ginkgo Bioworks shares in Q3 2024, an estimated $6.42K.
  • Kestra Private Wealth Services first reported a position in Ginkgo Bioworks in Q4 2022 and held it in 7 quarters.
  • Kestra Private Wealth Services's Ginkgo Bioworks position peaked at $41.7K in Q3 2023.
  • 159 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q3 2024.

Based on Kestra Private Wealth Services's 13F filing for Q3 2024, filed 13 Nov 2024.